• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovartis

Novartis

0
Novartis Zolgensma FDA
HealthNovartis Defends $2.1 Million Gene Therapy After FDA Data Manipulation Claims—Brainstorm Health
By Sy MukherjeeAugust 6, 2019
Novartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
LeadershipNovartis CEO: It’s Time to “Pivot Towards Transformational Innovation”
By Susie GharibMarch 20, 2019
Prescription bottles.
HealthNet Drug Prices Are Falling, Even as List Prices Increase
By Renae ReintsJanuary 30, 2019
Web Summit 2018 In Lisbon
HealthCanadian Pot Firm Tilray Goes Global With Novartis Marijuana Deal
By BloombergDecember 18, 2018
Biotech IPO Allogene
HealthWhy Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By Sy MukherjeeOctober 11, 2018
Novartis drug prices trump
HealthDrug Giant Novartis Is Temporarily Backing Off Price Increases Following Trump Pressure
By Sy MukherjeeJuly 19, 2018
SWITZERLAND-PHARMACEUTICAL-EARNINGS-HEALTH-NOVARTIS
HealthNovartis Is Spinning Off Its Alcon Eye Care Business and Launching a $5 Billion Share Buyback
By Sy MukherjeeJune 29, 2018
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
HealthThe FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By David MeyerMay 18, 2018
The American Enterprise Institute photo of Scott Gottlieb
HealthThe FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By Sy MukherjeeMay 17, 2018
US-POLITICS-INVESTIGATION-TRUMP-court
LeadershipTop Novartis Lawyer Exits Over the $1.2 Million It Paid to Trump Lawyer Michael Cohen
By David MeyerMay 16, 2018
US-POLITICS-INVESTIGATION-TRUMP-court
HealthThat $1.2 Million Payment to Trump’s Lawyer Wasn’t Even a Drop in the Bucket for Novartis
By Sy MukherjeeMay 10, 2018
Michael Cohen walks into NYC court
HealthNovartis Put Money In Michael Cohen’s Cookie Jar. Did It Get Any Cookies In Return?
By Clifton LeafMay 9, 2018
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By Sy MukherjeeJanuary 22, 2018
Iris Network Student
HealthThe First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By Sy MukherjeeDecember 19, 2017
Iris Network Student
HealthGene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
0
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
Energy
2 years ago, Saudi Arabia quietly canceled the ‘petrodollar’ deal with America that wired the world economy for 50 years. Then war broke out in Iranplaceholder alt text
By Fortune EditorsApril 7, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.